1. DCLK1 plays an important role in colorectal cancer tumorgenesis through the regulation of miR-200c
   Yasaman Mohammadi et al, 2018, Biomedicine & Pharmacotherapy CrossRef
2. Markers of pancreatic cancer stem cells and their clinical and therapeutic implications
   Arkadiusz Gzil et al, 2019, Mol Biol Rep CrossRef
3. Functional Significance and Therapeutic Potential of miR-15a Mimic in Pancreatic Ductal Adenocarcinoma
   Shixiang Guo et al, 2020, Molecular Therapy - Nucleic Acids CrossRef
4. Functional analysis of candidate genes from genome-wide association studies of hearing
   Neil J. Ingham et al, 2020, Hearing Research CrossRef
5. null
   Janani Panneerselvam et al, 2020 CrossRef
6. Saffron Crudes and Compounds Restrict MACC1-Dependent Cell Proliferation and Migration of Colorectal Cancer Cells
   Nazli Güllü et al, 2020, Cells CrossRef
7. Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy
   Karsten Krug et al, 2020, Cell CrossRef
8. Tuft and Cancer Stem Cell Marker DCLK1: A New Target to Enhance Anti-Tumor Immunity in the Tumor Microenvironment.
   Dongfeng Qu, 0 CrossRef
9. ATM Dysfunction in Pancreatic Adenocarcinoma and Associated Therapeutic Implications.
   Samantha A Armstrong et al, 2019, Mol Cancer Ther CrossRef
10. Mutations in key driver genes of pancreatic cancer: molecularly targeted therapies and other clinical implications
    Hai-feng Hu et al, 2021, Acta Pharmacol Sin CrossRef
11. Inhibition of DCLK1 with DCLK1-IN-1 Suppresses Renal Cell Carcinoma Invasion and Stemness and Promotes Cytotoxic T-Cell-Mediated Anti-Tumor Immunity
    Ling Ding et al, 2021, Cancers CrossRef
12. Roles of Dclk1 in the Pathogenesis, Diagnosis, Prognosis and Treatment of Pancreatic Cancer: A Review
    Yifan Wang et al, 2021, Expert Review of Gastroenterology & Hepatology CrossRef
13. Targeting DCLK1 overcomes 5‐fluorouracil resistance in colorectal cancer through inhibiting CCAR1/β‐catenin pathway‐mediated cancer stemness
    Lanqing Wang et al, 2022, Clinical & Translational Med CrossRef
14. Effective combinations of anti-cancer and targeted drugs for pancreatic cancer treatment
    Arata Nishimoto, 2022, WJG CrossRef
15. Pleiotropic effects of DCLK1 in cancer and cancer stem cells
    Dibyashree Chhetri et al, 2022, Front. Mol. Biosci. CrossRef
16. DCLK1 and its oncogenic functions: A promising therapeutic target for cancers
    Liu Ye et al, 2023, Life Sciences CrossRef